ANNA YEO
is a video producer and self-taught animator based in Boston and New York. This is her landing page.
In 2024, she earned an Online Journalism Award for a video she produced at STAT about in utero gene editing.
Her work as a documentary associate producer includes the New York Times Critic’s Pick Try Harder! (2021).
She holds a B.A. in Economics and Film Studies from Wesleyan University.
She also takes photos!
annamariayeo@gmail.com
/annamyeo
Affiliations: A-Doc, AAJA, Brown Girls Doc Mafia, Video Consortium STAT: What is in utero gene editing?
I produced, animated, and edited this video to accompany a STAT profile on fetal surgeon Tippi MacKenzie and her work.
In 2024, this video received an Online Journalism Award for Short Form Digital Video Storytelling (Small/Medium Newsroom).
What is in utero gene editing?
Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?
In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.
Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.